Neural stemness contributes to cell tumorigenicity.
Differentiation potential
Evo-devo
Neural ground state
Neural stem/progenitor cell
Neural stemness
Tumor-initiating cell
Tumorigenesis
Tumorigenicity
Journal
Cell & bioscience
ISSN: 2045-3701
Titre abrégé: Cell Biosci
Pays: England
ID NLM: 101561195
Informations de publication
Date de publication:
19 Jan 2021
19 Jan 2021
Historique:
received:
29
07
2020
accepted:
05
01
2021
entrez:
20
1
2021
pubmed:
21
1
2021
medline:
21
1
2021
Statut:
epublish
Résumé
Previous studies demonstrated the dependence of cancer on nerve. Recently, a growing number of studies reveal that cancer cells share the property and regulatory network with neural stem/progenitor cells. However, relationship between the property of neural stemness and cell tumorigenicity is unknown. We show that neural stem/progenitor cells, but not non-neural embryonic or somatic stem/progenitor cell types, exhibit tumorigenicity and the potential for differentiation into tissue types of all germ layers when they are placed in non-native environment by transplantation into immunodeficient nude mice. Likewise, cancer cells capable of tumor initiation have the property of neural stemness because of their abilities in neurosphere formation in neural stem cell-specific serum-free medium and in differentiation potential, in addition to their neuronal differentiation potential that was characterized previously. Moreover, loss of a pro-differentiation factor in myoblasts, which have no tumorigenicity, lead to the loss of myoblast identity, and gain of the property of neural stemness, tumorigenicity and potential for re-differentiation. By contrast, loss of neural stemness via differentiation results in the loss of tumorigenicity. These suggest that the property of neural stemness contributes to cell tumorigenicity, and tumor phenotypic heterogeneity might be an effect of differentiation potential of neural stemness. Bioinformatic analysis reveals that neural genes in general are correlated with embryonic development and cancer, in addition to their role in neural development; whereas non-neural genes are not. Most of neural specific genes emerged in typical species representing transition from unicellularity to multicellularity during evolution. Genes in Monosiga brevicollis, a unicellular species that is a closest known relative of metazoans, are biased toward neural cells. We suggest that the property of neural stemness is the source of cell tumorigenicity. This is due to that neural biased unicellular state is the ground state for multicellularity and hence cell type diversification or differentiation during evolution, and tumorigenesis is a process of restoration of neural ground state in somatic cells along a default route that is pre-determined by an evolutionary advantage of neural state.
Sections du résumé
BACKGROUND
BACKGROUND
Previous studies demonstrated the dependence of cancer on nerve. Recently, a growing number of studies reveal that cancer cells share the property and regulatory network with neural stem/progenitor cells. However, relationship between the property of neural stemness and cell tumorigenicity is unknown.
RESULTS
RESULTS
We show that neural stem/progenitor cells, but not non-neural embryonic or somatic stem/progenitor cell types, exhibit tumorigenicity and the potential for differentiation into tissue types of all germ layers when they are placed in non-native environment by transplantation into immunodeficient nude mice. Likewise, cancer cells capable of tumor initiation have the property of neural stemness because of their abilities in neurosphere formation in neural stem cell-specific serum-free medium and in differentiation potential, in addition to their neuronal differentiation potential that was characterized previously. Moreover, loss of a pro-differentiation factor in myoblasts, which have no tumorigenicity, lead to the loss of myoblast identity, and gain of the property of neural stemness, tumorigenicity and potential for re-differentiation. By contrast, loss of neural stemness via differentiation results in the loss of tumorigenicity. These suggest that the property of neural stemness contributes to cell tumorigenicity, and tumor phenotypic heterogeneity might be an effect of differentiation potential of neural stemness. Bioinformatic analysis reveals that neural genes in general are correlated with embryonic development and cancer, in addition to their role in neural development; whereas non-neural genes are not. Most of neural specific genes emerged in typical species representing transition from unicellularity to multicellularity during evolution. Genes in Monosiga brevicollis, a unicellular species that is a closest known relative of metazoans, are biased toward neural cells.
CONCLUSIONS
CONCLUSIONS
We suggest that the property of neural stemness is the source of cell tumorigenicity. This is due to that neural biased unicellular state is the ground state for multicellularity and hence cell type diversification or differentiation during evolution, and tumorigenesis is a process of restoration of neural ground state in somatic cells along a default route that is pre-determined by an evolutionary advantage of neural state.
Identifiants
pubmed: 33468253
doi: 10.1186/s13578-021-00531-6
pii: 10.1186/s13578-021-00531-6
pmc: PMC7814647
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21Subventions
Organisme : National Natural Science Foundation of China
ID : 31671499
Références
Nature. 2008 Aug 21;454(7207):955-60
pubmed: 18719581
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):6406-6411
pubmed: 28484005
Regen Med. 2018 Mar;13(2):219-232
pubmed: 29509072
Cancers (Basel). 2011 Jul 22;3(3):3002-17
pubmed: 24310356
Histopathology. 1997 Nov;31(5):465-8
pubmed: 9416488
Nature. 2010 Aug 5;466(7307):720-6
pubmed: 20686567
Nat Genet. 2014 Jun;46(6):595-600
pubmed: 24793135
Stem Cells Transl Med. 2014 Oct;3(10):1182-7
pubmed: 25122691
Cell Biosci. 2017 Nov 7;7:61
pubmed: 29177029
Nat Commun. 2016 Feb 29;7:10798
pubmed: 26924072
BMC Biol. 2010 May 21;8:66
pubmed: 20492640
PLoS Med. 2009 Feb 17;6(2):e1000029
pubmed: 19226183
Clin Cancer Res. 2011 Apr 1;17(7):1741-52
pubmed: 21350004
Nature. 2019 May;569(7758):672-678
pubmed: 31092925
Science. 2000 Jun 2;288(5471):1660-3
pubmed: 10834848
Oncogene. 2009 May 7;28(18):1960-70
pubmed: 19330021
Nat Rev Cancer. 2011 Apr;11(4):268-77
pubmed: 21390058
J Cell Biol. 2006 Jan 2;172(1):79-90
pubmed: 16390999
Front Genet. 2019 May 03;10:422
pubmed: 31130994
World J Gastroenterol. 2006 Dec 28;12(48):7878-83
pubmed: 17203538
Mod Pathol. 2016 Dec;29(12):1532-1540
pubmed: 27562493
BMC Genomics. 2016 Mar 12;17:225
pubmed: 26968808
Nature. 2015 Jun 4;522(7554):89-93
pubmed: 25762136
Neuron. 2015 Apr 22;86(2):353-5
pubmed: 25905808
J Biol Chem. 2017 Aug 4;292(31):12842-12859
pubmed: 28634230
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):6160-6162
pubmed: 28584134
EMBO Rep. 2014 Mar;15(3):244-53
pubmed: 24531722
Cold Spring Harb Symp Quant Biol. 2008;73:171-4
pubmed: 19150965
Cancer Cell. 2018 Jan 8;33(1):108-124.e5
pubmed: 29316425
Elife. 2013 Dec 17;2:e01197
pubmed: 24347544
Radiographics. 2019 May-Jun;39(3):626-629
pubmed: 31059400
Trends Genet. 2007 Nov;23(11):533-9
pubmed: 18029048
Cell Transplant. 2012;21(8):1603-11
pubmed: 22776287
Nat Commun. 2015 Mar 09;6:6367
pubmed: 25751731
Cancer Cell. 2017 Mar 13;31(3):342-354
pubmed: 28292437
Cell Res. 2014 Jun;24(6):665-79
pubmed: 24638034
Cancer. 2011 Nov 1;117(21):4834-45
pubmed: 21480205
Signal Transduct Target Ther. 2017 Jan 06;2:16036
pubmed: 29263908
Nat Biotechnol. 2003 Feb;21(2):183-6
pubmed: 12524553
Nat Rev Neurosci. 2002 Apr;3(4):271-80
pubmed: 11967557
J Anat. 2010 Sep;217(3):203-13
pubmed: 20646110
Cell Rep. 2020 Feb 11;30(6):1724-1734.e4
pubmed: 32049006
Stem Cells Int. 2018 Feb 4;2018:5653787
pubmed: 29535771
Proc Natl Acad Sci U S A. 1970 Nov;67(3):1521-7
pubmed: 5274476
Sci Transl Med. 2014 Aug 20;6(250):250ra115
pubmed: 25143365
Ann Surg. 2010 May;251(5):923-31
pubmed: 20395845
Stem Cells Dev. 2011 Aug;20(8):1297-308
pubmed: 21303266
Nature. 2008 Feb 14;451(7180):783-8
pubmed: 18273011
Neuron. 2001 Apr;30(1):65-78
pubmed: 11343645